Position in PRGO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$16,964,997
+$6,211,382 QoQ
Shares Held
1,632,820
+63.1% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 334 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 4%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $2,153,058,366 across 55 Drug Manufacturers - Specialty & Generic names. PRGO ranks #20 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,542,234 | $398,264,931 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,956,873 | $269,578,854 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
430,844 | $233,444,201 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,259,717 | $212,312,700 | |
| 5 | VTRS |
Viatris Inc
|
10,038,691 | $159,414,410 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,256,056 | $104,741,534 | |
| 7 | ALKS |
Alkermes plc.
|
1,831,619 | $95,976,834 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
818,394 | $90,792,627 |
All Filings in PRGO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,964,997 | 1,632,820 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $10,753,615 | 1,001,268 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $14,551,422 | 1,045,361 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $28,696,228 | 1,288,560 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $37,550,815 | 1,405,345 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $39,958,820 | 1,425,065 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $35,737,079 | 1,390,007 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $30,004,731 | 1,143,909 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $28,825,438 | 1,122,486 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $32,575,248 | 1,011,968 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $49,178,955 | 1,528,246 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $50,568,254 | 1,582,731 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $53,585,252 | 1,578,358 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $58,504,506 | 1,631,015 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $52,380,136 | 1,536,525 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $55,185,953 | 1,547,559 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $58,988,373 | 1,453,990 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $53,912,369 | 1,402,872 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $50,323,682 | 1,293,668 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $63,402,983 | 1,339,594 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $55,000,189 | 1,199,568 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $51,598,842 | 1,274,990 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $67,827,536 | 1,516,716 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $74,134,868 | 1,614,787 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $92,780,365 | 1,678,675 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $76,783,858 | 1,596,670 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||